Theranica Expands Accessibility of Nerivio™ to U.S. Migraine Patients Via Partnership With Telemedicine Platform, Cove

Cove Provides Rapid Consultation with a Licensed Physician and Home Delivery of the Novel FDA-Authorized Prescribed Wearable Device

NETANYA, Israel, and NEW YORK, Feb. 25, 2020 /PRNewswire/ — Theranica Bioelectronics (Theranica), a bio-medical technology company developing advanced electroceuticals for migraine and other pain conditions, and Cove, a healthcare company that provides increased access to innovative migraine treatments, alongside ongoing migraine management, announced today the expanded availability of Nerivio™, a novel FDA-authorized prescribed wearable for acute treatment of migraine, on Cove’s advanced telemedicine platform. Read more…